Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RENB
- Price
- 3.41
- Stock movement down
- -0.03 (-1.38%)
- Company name
- Renovaro Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsverdi
- 52.84M
- Ent verdi
- -
- Pris/omsetning
- -
- Pris/bok
- -
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- -65.85%
- 3 års avkastning
- -55.29%
- 5 års avkastning
- -44.12%
- 10 års avkastning
- -
Sist oppdatert: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UTBYTTE
RENB betaler ikke utbytte
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | - |
| Pris til bok | - |
| EV i forhold til salg | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
ØKONOMI
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 2.26 |
| Daglig høy | 2.35 |
| Daglig lav | 2.25 |
| Daglig volum | 35K |
| Tidenes høyeste | 125.50 |
| 1 år analytikerestimat | - |
| Beta | 0.53 |
| EPS (TTM) | - |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | 29 Sep 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| RENB | S&P500 | |
| Nåværende prisfall fra toppnotering | -98.18% | -1.46% |
| Høyeste prisfall | -98.21% | -56.47% |
| Dato for høyeste fall | 7 Aug 2025 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -59.32% | -10.99% |
| Gj.snittlig tid til ny topp | 59 days | 12 days |
| Maks tid til ny topp | 935 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
SELSKAPSOPPLYSNINGER
Markedsverdi
52.84M
Markedsverdi kategori
Small-cap
Beskrivelse
Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company has a strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The company was formerly known as Renovaro Biosciences Inc. and changed its name to Renovaro Inc. in February 2024. Renovaro Inc. is headquartered in Los Angeles, California.
Ansatte
25
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
USA
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Seeking AlphaPressemeldinger
iO Charts is a Seeking Alpha partnerNeste side